| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |